Table 8.
The immunohistochemical (IHC) features of 9 patients
| NO./age | GTN pathological type | IHC report | Status |
|---|---|---|---|
| 1/26 | ETT | HCG−, HPL+/+−, P63++, P53− | NED |
| 2/28 | ETT | HCG+, HPL+ | Lost |
| 3/36 | Choriocarcinoma, ETT | HCG scattered+, HPL scattered+, P63++, SALL4− | NED |
| 4/40 | Choriocarcinoma | HCG+, HPL− | Dead |
| 5/45 | ETT | HCG extensive+, HPL+, P53− | NED |
| 6/26 | Choriocarcinoma | HCG++, HPL+++, P63− | NED |
| 7/42 | PSTT | HCG+, HPL+, P63+ | NED |
| 8/48 | Choriocarcinoma, ETT | HCG+, HPL partial+, P63 partial+, SALL4− | Under treatment after recurrence(sensitive to chemotherapy) |
| 9/46 | Choriocarcinoma | HCG+, HPL partial+, P53 90%++, p63 little+ | Dead |
HPL human placental lactogen